MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
January 25, 2005
Stephen D. Simpson
Prognosis Good for Merck The pharmaceutical weathered a tough year but should ride out its Vioxx troubles. While strict value investors may be put off, risk-tolerant investors can buy these shares today. mark for My Articles similar articles
The Motley Fool
April 5, 2005
Selena Maranjian
Don't Be a Simple-Minded Investor One mistake that many beginning investors (and some seasoned investors, as well) make is to put too much stock in one or a few measures as they evaluate companies as possible investments. mark for My Articles similar articles
The Motley Fool
November 14, 2005
Tim Beyers
Guarantee Your Returns Learning to invest is easy. Learning to beat the market isn't. That's why, over the course of decades, some of the best money managers in the business have relied on dividends for help. mark for My Articles similar articles
The Motley Fool
January 13, 2006
Nathan Parmelee
High Yield Isn't Always High Risk Time to change your thinking about high-yielding stocks. Investors who assume all high-yielding stocks carry with them higher levels of risk are shutting themselves out of profitable investment opportunities. mark for My Articles similar articles
The Motley Fool
September 19, 2005
Nathan Slaughter
Better Total Returns There's an easy way to do better, and it doesn't involve taking on more risk. Understanding that yield is a major component of total return is easy enough; putting that knowledge to work in your portfolio is the real test. mark for My Articles similar articles
The Motley Fool
April 26, 2004
Mathew Emmert
Powerful Payouts Stock yields are still better than some might suggest. Have a look at why current dividend yields are anything but puny and what they can add to your bottom line. mark for My Articles similar articles
The Motley Fool
September 2, 2005
Nathan Parmelee
3 Stocks That Can Pay More Dividend growth is as important as the dividend itself. Here are three stocks that make the dividend growth cut. Polaris Industries... Nokia... Kimberly-Clark... mark for My Articles similar articles
The Motley Fool
October 8, 2004
Whitney Tilson
Blue-Chip Bargains? Sifting through beaten-down stocks may yield some good investments. But be careful, most of these stocks are that way for a reason. mark for My Articles similar articles
The Motley Fool
December 21, 2006
Brian Lawler
Dueling Fools: Merck Bull What you are getting with Merck is one of the best-managed pharmas out there that will be experiencing solid double-digit earnings growth in the not-too-distant future with a smart dividend payout. mark for My Articles similar articles
The Motley Fool
January 13, 2005
Selena Maranjian
Big Dividend Payers Big dividend payers can reward you well, but select carefully. mark for My Articles similar articles
The Motley Fool
March 9, 2009
Brian Orelli
Merck-Schering Trumps Pfizer-Wyeth The new Merck deal looks a lot better than a combined Pfizer plus Wyeth. mark for My Articles similar articles
The Motley Fool
December 21, 2006
Ryan Fuhrmann
Dueling Fools: Merck Bear Investors, because of its recent run-up, the risk/reward tradeoff is not very compelling. There are safer, more lucrative ways to invest in the space. mark for My Articles similar articles
The Motley Fool
May 3, 2006
Selena Maranjian
When Dividends Are Dicey A hefty dividend yield isn't always something investors can count on. mark for My Articles similar articles
The Motley Fool
January 23, 2006
Selena Maranjian
Money Making Money Put the snowball principle to work for your portfolio. But it is important to study dividend-paying candidates (and any stock you're considering, for that matter) carefully. mark for My Articles similar articles
The Motley Fool
December 17, 2004
Tim Beyers
Give the Gift of Cash No gift lifts sagging returns more than cold, hard moolah by way of dividends. Here's some underpriced stocks that give like Santa: New York Community Bank... Knightsbridge Tankers... BB&T... etc. mark for My Articles similar articles
The Motley Fool
April 26, 2006
Tim Beyers
Where the Yields Are The best dividend payers are perhaps not where you think. Great businesses that boast high yields can be found in any industry, as long as you broaden your search to overseas markets. mark for My Articles similar articles
The Motley Fool
September 8, 2004
Tim Beyers
What Is a Good Dividend? One expert tours the market to find out what makes a worthwhile dividend. mark for My Articles similar articles
The Motley Fool
September 30, 2004
W. D. Crotty
Merck Chokes Back Vioxx The $2.3 billion arthritis drug is withdrawn from the market after clinical studies point to dangerous side-effects. Despite the bad news, Merck's big dividend payouts don't appear to be in jeopardy at the moment. mark for My Articles similar articles
The Motley Fool
September 27, 2004
Mathew Emmert
How to Be a Dividend Investor Here are the tools you need to build a diverse portfolio of high-quality, dividend-paying investments. Read on to learn a few things about evaluating the power of the payout. mark for My Articles similar articles
The Motley Fool
June 10, 2005
Selena Maranjian
How Not to Value Stocks Don't confuse price tags with intrinsic value. A stock's price alone is much less meaningful than you may think. mark for My Articles similar articles
The Motley Fool
April 26, 2005
Tim Hanson
More Money, Less Risk In good times and bad, dividends deliver the best of the market. mark for My Articles similar articles
The Motley Fool
June 5, 2006
Chuck Saletta
Get Paid for Your Patience You can beat the market over time with a dividend-focused strategy. Such a strategy will also assure that you get paid while you wait for the market to realize just how valuable your companies truly are. mark for My Articles similar articles
The Motley Fool
March 15, 2004
Bill Mann
Don't Be a "Yield Pig" Is an 8% dividend yield better than a 4% yield? "Not necessarily," says Bill Mann. After the change in the tax treatment of dividends last year, investors suddenly started valuing dividend-paying companies slightly higher. mark for My Articles similar articles
The Motley Fool
February 27, 2006
Tim Beyers
The Agony of Dividend Defeat In the Olympics, it takes only one tiny slip. The same goes for your portfolio. Buy stock only in dividend payers that pass the test, and then routinely reinvest the proceeds. mark for My Articles similar articles
The Motley Fool
November 22, 2005
Stephen D. Simpson
Diving Into The Dow: The Fifth Five The authors banter about the relative merits and investment opportunities of some the biggest companies in America: McDonald's... Merck... Microsoft... Pfizer... Procter & Gamble... mark for My Articles similar articles
The Motley Fool
August 22, 2005
Mathew Emmert
Dividend Stocks Beat the Market Let dividends lead you to miraculous investment returns. mark for My Articles similar articles
The Motley Fool
April 18, 2006
Seth Jayson
Play the Right Numbers As an investor, you might be able to learn something from the bookies out there. Investing in solid dividend-paying companies beats the market with lower risk. mark for My Articles similar articles
The Motley Fool
April 21, 2009
Brian Orelli
Schering and Merck: A Match Made in Purgatory Until Merck can show that it's capable of growing sales again, investors should be leery of stepping in, even with the dividend yield pushing 6%. mark for My Articles similar articles
The Motley Fool
December 21, 2006
Ryan Fuhrmann
Dueling Fools: Merck Bear Rebuttal Yes, Merck is a good company, but investors can still do better. mark for My Articles similar articles
The Motley Fool
May 19, 2005
Tim Hanson
The Power of Free Money Hear that Drip? It's your portfolio growing. The best candidates for Drips (dividend reinvestment plans) are stocks that increase dividends regularly and appreciate in the market. mark for My Articles similar articles
The Motley Fool
February 22, 2005
Charly Travers
Is Big Pharma a Bargain? While much of the drug sector is looking pretty tasty, Pfizer, with its attractive relative valuation, dominant marketing presence, and willingness to buy up blockbuster drugs, heads the list. mark for My Articles similar articles
The Motley Fool
March 1, 2004
Mathew Emmert
How to Be an Income Investor Develop a high-quality, income-producing portfolio now. Provided are the tools you need to build a diverse portfolio of high-quality, income-producing investments. mark for My Articles similar articles
The Motley Fool
November 25, 2011
Dan Caplinger
Has Merck Become the Perfect Stock? Like most other pharma companies, Merck is dealing with the imminent loss of patent protection on one of its blockbuster drugs. mark for My Articles similar articles
The Motley Fool
February 10, 2006
Tim Hanson
Good Stocks to Buy Now Put the market to work for you -- today: Altria... Abbot Labs... Bristol-Myers... Tootsie Roll... Pfizer... Coca-Cola... Merck... mark for My Articles similar articles
The Motley Fool
July 16, 2010
Eric Bleeker
Buy, Sell, or Hold Frontier Communications? Should dividend-focused investors be looking to Frontier as an all-star candidate for their portfolio? Is a dividend of this size sustainable? To discern this, here's a list of reasons to buy, sell, or hold Frontier Communications. mark for My Articles similar articles
The Motley Fool
January 6, 2006
Tim Hanson
Hit the High-Yield Jackpot Are your dividends too good to be true? High-yield stocks are only worthwhile when investors receive the advertised return. mark for My Articles similar articles
The Motley Fool
February 14, 2009
Ilan Moscovitz
The Next 3 Dividend Dynamos A few stock ideas for this market. mark for My Articles similar articles
The Motley Fool
August 25, 2004
Ben McClure
Baby Bells' Silver Lining While these might be gloomy days for telecommunications stocks, it's too early to count Verizon, BellSouth, and SBC Communications out. mark for My Articles similar articles
The Motley Fool
November 25, 2009
Jennifer Schonberger
7 Dividend Divas Check out these income stocks for steady dividend returns: Alliance Resource Partners... Altria Group... AT&T... Bristol-Myers Squibb... Southern Company... Eli Lilly... Verizon... mark for My Articles similar articles
The Motley Fool
February 15, 2006
Selena Maranjian
We Buy What We See In investing, your selection is limited. Here are a few tips to help you find better investments. mark for My Articles similar articles
The Motley Fool
May 11, 2005
Brian Richards
What Every Portfolio Needs Want a strong core investment? Look no further than dividend-paying stocks. mark for My Articles similar articles
The Motley Fool
April 3, 2006
Tim Hanson
Stocks Worth Forgetting It's as simple as a fire drill: Buy, hold, and reinvest. These are exactly the kinds of stocks you can buy and forget about: Sysco... Bank of America... Pitney Bowes... etc. mark for My Articles similar articles
The Motley Fool
December 23, 2005
Nathan Parmelee
The Investing Strategy That Keeps Giving The best results from dividends require patience, a long-term time horizon, and excellent companies for your investment dollars. mark for My Articles similar articles
The Motley Fool
January 31, 2007
Brian Lawler
Merck Plays the Waiting Game New acquisitions may help the drugmaker weather tough times. Investors, take note. mark for My Articles similar articles
The Motley Fool
May 31, 2005
Nathan Parmelee
Following a Master Investor's Lead A look at how one leading investment mind crushed the market by focusing on dividends. John Neff's long-term record of success is ample proof that dividends are where it's at. mark for My Articles similar articles
The Motley Fool
October 30, 2009
Dan Caplinger
Should You Dump These Dividend Stocks? After the market's big rally, many stocks have seen their dividend yields drop sharply. Do those falling yields mean that you should get out of these dividend stocks now before it's too late? mark for My Articles similar articles
The Motley Fool
August 22, 2005
Stephen D. Simpson
Vioxx Brings the Pain A jury stings Merck for hefty Vioxx damages, battering shares. mark for My Articles similar articles
BusinessWeek
December 22, 2003
Robert Barker
A Stimulant For Depressed Drug Stocks? For a bunch of can't-miss stocks, the big drugmakers sure did miss out on 2003's bull run. The dozen drug companies in the Standard & Poor's 500-stock index have returned 10% this year, vs. the index' 22%. But the market is now failing to credit the companies' strengths. mark for My Articles similar articles
The Motley Fool
June 8, 2009
Selena Maranjian
Double Your Dividends in Six Years Here's how you can collect thousands of dollars annually (and easily). mark for My Articles similar articles
The Motley Fool
August 13, 2010
Ilan Moscovitz
Merck: Dividend Dynamo or Disaster? Just how safe is this dividend? mark for My Articles similar articles